Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-21-082070

Options or other derivatives

  • Chief Financial Officer acquired 37,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bellemin Jean-Marc · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-14 Grant or award : show line 1 in the form Restricted Stock Units +37,700 37,700 D
Loading xslF345X03/tm2119923-4_4seq1.xml…